PLAB vs ICHR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PLAB

40.1
AI Score
VS
ICHR Wins

ICHR

41.5
AI Score

Investment Advisor Scores

PLAB

40score
Recommendation
HOLD

ICHR

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PLAB ICHR Winner
Revenue 651.05M 550.85M PLAB
Net Income 103.28M -1.47M PLAB
Gross Margin 33.2% 13.3% PLAB
Net Margin 15.9% -0.3% PLAB
Operating Income 142.54M 9.28M PLAB
ROE 8.1% -0.2% PLAB
ROA 5.2% -0.1% PLAB
Total Assets 1.99B 1.19B PLAB
Cash 549.51M 256.46M PLAB
Current Ratio 4.94 3.70 PLAB
Free Cash Flow 90.20M -33.63M PLAB

Relative Price Performance (Last 90 Days)

PLAB 1M: +13.0% · 3M: +7.8% ICHR 1M: +19.6% · 3M: -34.2%

Current Technical Phase

PLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.8 · Price: $31.49

ICHR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $62.92

Fundamentals Snapshot

Metric PLAB ICHR
Market Cap — —
Forward P/E 15.2 19.3
Trailing P/E 11.0 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.3% 0.1%
Operating Margin 0.2% 0.0%
EPS 2.81 -1.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ICHR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.